geneic. These include leukocyte, PMN, monocyte and platelet counts. 6,7 Early and accurate determination of engraftment, especially of granulocyte regeneration, is of Highly fluorescent reticulocyte (HFR) counts were evaluated in 13 consecutive patients affected by hematogreat clinical importance as much as the early diagnosis of engraftment failure in order to give timely appropriate logical malignancies and submitted to autologous selected CD34
6,7
Early and accurate determination of engraftment, especially of granulocyte regeneration, is of Highly fluorescent reticulocyte (HFR) counts were evaluated in 13 consecutive patients affected by hematogreat clinical importance as much as the early diagnosis of engraftment failure in order to give timely appropriate logical malignancies and submitted to autologous selected CD34
+ peripheral blood progenitor cell (PBPC) treatment. Although reticulocyte count does not provide accurate information on hemopoietic recovery, the subfractransplantation. Results were compared with a historical group of patients comparable for age, disease and tion of the RNA richest reticulocytes, so called HFR (highly fluorescent reticulocytes), represent the earliest conditioning regimen submitted to unfractionated PBPC transplantation. HFR counts of the CD34 + group indicator of engraftment in the autologous and allogeneic bone marrow transplantation setting, clearly preceding declined to an undetectable level from day +4 to day +10 when they became detectable and reached 5% of PMN recovery.
8,9
In this study we investigated HFR recovery and their total reticulocyte count by day +12. In the historical group, the nadir was identical but the recovery was fasbehavior during hemopoietic recovery in 13 patients submitted to immunoselected autologous PBPC CD34 + transter (day +9). Total reticulocyte count Ͼ1% was achieved at days +17 and +11, respectively. The absolute neutroplantation, considering that this procedure virtually depletes the inoculum of all committed progenitors lacking CD34 phil count (ANC) recovery was identical in both groups, achieving a value Ͼ0.5 × 10 9 /l at day +13 after reinexpression on their surface. Results are compared to a historical control group of patients submitted to unfractionated fusion. Hence, in the historical group, HFR count gave advance notice of complete and stable hemopoietic PBPC transplantation. engraftment while in the CD34 + group HFR and ANC count showed almost simultaneous recovery. Keywords: HFR; reticulocytes; CD34 + peripheral blood Patients and methods progenitor cells transplantation Thirteen consecutive patients, median age 50 years (range 31-59), six females and seven males receiving autologous peripheral blood CD34 + progenitor cell transplantation Autologous transplantation of PBPC is currently used as a were included in this study. Six patients were affected by routine procedure in hematological malignancies. 1 Hemomultiple myeloma (MM), six by non-Hodgkin's lymphoma poietic recovery is prompt and self-sustaining and easily (NHL) and one by Hodgkin's disease (HD). All patients reproducible despite different conditioning regimens and were in partial remission before transplantation and all but previous history of the underlying disease.
2 If the safety of one had bone marrow involvement at diagnosis. Patients' PBPC is unquestionable in terms of hemopoietic rescue, characteristics are listed in Table 1 . The historical group their contribution to disease recurrence is still a matter of included 15 patients, eight females and seven males debate. Various attempts have been made to reduce or abro-(median age 46 years; range 18-62) affected by NHL gate tumor contamination of blood and bone marrow hemo-(seven patients), HD (two patients), MM (two patients), poietic progenitors and different strategies have been ANLL (four patients) and submitted to unfractionated employed.
3 Immunoselection of CD34 + cells is one of the PBPC transplantation. Patients in the historical group were recent methods used to obtain depletion of malignant cells comparable in terms of age, disease and conditioning regiwhile retaining a good recovery of hemopoietic stem men. G-CSF was not given after reinfusion. Characteristics cells.
4,5 Nevertheless, purging procedures result in a sigof these patients are listed in Table 2 . Mobilization protocol nificant delay of hemopoietic recovery after transplantation.
and leukapheretic technique are reported elsewhere in Several criteria have been proposed over the years to detail. 10 CD34 + progenitor selection was carried out using evaluate the complete and self-sustained engraftment after the CEPRATE SC system (Cellpro, Bothell, WA, USA). bone marrow transplantation, either autologous or allo-
In the study population, conditioning regimen was BuCy2 in three patients, BEAM in two patients and BUMEL in the remaining eight patients. After the conditioning regimen UPN = unique patient number; ANC = absolute neutrophil count; SDU = single donor unit; HFR = highly fluorescence reticulocytes; RET = reticulocytes; NA = not achieved.
taneously from day +7 after reinfusion until a stable ANC age of HFR were estimated using a Sysmex R-1000 tm (Merck, Clevenot, France) (TOA Medical Electronics Co, Ͼ0.5 × 10 9 /l was obtained for at least 3 consecutive days. G-CSF was administered after transplantation for a median Kobe, Japan) a fully automated flow cytometric reticulocyte counter. 11 HFR are expressed as a percentage of total retiof 11 days (range 4-18). Erythropoietin was not given after transplantation.
culocytes. Packed RBC were transfused to maintain the hemoglobin concentration at Ͼ8.0 g/dl and platelet transfusions to keep Statistical analysis the platelet count at Ͼ15 × 10 9 /l. All blood products were
The relationship between the time in days from PBPCT to irradiated with 15 Gy. a level of 5% HFR and the attainment of given levels of Engraftment was defined as HFR count of 5% of total reticulocytes and neutrophils was studied by the Mannreticulocytes, ANC Ͼ0.5 × 10 9 /l, stable platelet count Whitney test. Statistical significance was defined as Ͼ50 × 10 9 /l and independence of RBC transfusion. P Ͻ 0.05.
Analysis of peripheral blood counts
Results Full blood counts were carried out daily from day −6 to day +18 after reinfusion and weekly thereafter. Hemograms
Results are expressed as median values and data reported here are particularly focused on the first 3 weeks after and WBC differential counts were obtained with Bayer Technicon system H3. Reticulocyte counts and the percentreinfusion.
HFR after CD34
+ peripheral blood progenitor cell transplantation S Sica et al In all patients the reticulocyte count and HFR fell progressively after the conditioning regimen to a nadir at day +4 followed by a plateau until day +10 when HFR began to rise achieving a stable value Ͼ5% by day +12 (range 10-26). Patients in the control group exhibited a different behavior with a prompt rise to a stable value of HFR Ͼ5% at day +9 (P = 0.001) (Figure 1) . A reticulocyte count Ͼ1% was obtained in the CD34
+ PBPC transplantation group at day +16 (range 12-28) vs day +11 in the control group (P = 0.001) (Figure 2) . Thus, HFR preceded the total reticulocyte rise by 4 days after CD34 + PBPCT and 2 days after unfractionated PBPCT.
The recovery of ANC Ͼ 0.5 × 10 9 /l was almost identical in the two groups with a median of 13 days after reinfusion (P = NS) (Figure 3) .
In the control group, HFR values Ͼ5% clearly preceded the ANC recovery by at least 4 days while in the CD34 + PBPC transplantation the recovery of HFR was almost identical to ANC recovery (days +12 and +13, respectively) (Figure 4a and b) . Platelet recovery to Ͼ50 × 10 9 /l was obtained at a median of 36 days (range 15-Ͼ60) after CD34
+ PBPCT and at a median of 11 days (range 0-155) after unfractionated PBPCT (P = 0.001).
Blood transfusion support consisted of a median of 3 units of pRBC (range 1-8) and 2 units single donor platelet (range 1-7) after CD34 + PBPCT (P = 0.003) and a median The median length of hospitalization was 29 days (range 24-49) after CD34 + PBPCT and 24 days (range 18-52) after unfractionated PBPCT (P = 0.04). hemopoietic reconstitution were evaluated in patients sub-
Discussion

